An Observational, Ambispective Cohort Study Evaluating the Long-term Effectiveness and Safety of Dinutuximab Beta or Conventional Treatment as Maintenance Therapy in Patients With High Risk Neuroblastoma

03/05/2022
02/07/2024
EU PAS number:
EUPAS46562
Study
Ongoing
Documents
Study protocol
Study results
Study report
Other information